On this note, nucleic acids deliveries are truly advantageous tools as they allow the systemic delivery of potentially toxic molecules that can be combined with chemotherapy aiming at terminating

possible resistant-tumor cells. As an example, recently, Su and collaborators have reported on an antitumor strategy combining TNF-encoding pDNA and chemotherapy [68]. While systemically administered TNF is extremely toxic, in its genetic form, and when reaching specific target cells, TNF revealed Inhibitors,research,lifescience,medical to be a powerful antitumor agent. Specific and efficient are indeed key words in this type of targeted approaches,

as in suicide gene delivery. It is Inhibitors,research,lifescience,medical thus of extreme importance to thoroughly evaluate the target options and to verify the levels of the target molecule in the cells of interest. The activation of possible target-receptors may be desired, such as in the case reported by Poeck et al. Inhibitors,research,lifescience,medical [116], but only when not hampering the therapeutic effect by activation of pathways that can lead to cell proliferation/differentiation, enhanced cell migration, or inhibition of apoptosis. As described by Schäfer et al., this can be the case when targeting the epidermal growth factor receptor (EGFR), and it is then desirable to design a ligand that targets the receptor circumventing its activation [144]. On the other hand, the

relevance of analyzing the Inhibitors,research,lifescience,medical targeted receptor has been well exposed in the short letter Inhibitors,research,lifescience,medical of Perris in response to the work published by Davis et al. [138]. To avoid other pitfalls in nanovector development, also the in vivo distribution needs to be assessed, preferably by several http://www.selleckchem.com/products/Belinostat.html approaches (e.g., bioluminescence imaging, positron emission tomography (PET), and magnetic resonance imaging (MRI)). To this end, immunohistochemistry studies may be suitable and very convenient to corroborate and support data collected by different means, but also Anacetrapib microscopy (mostly in vitro but also histochemistry analysis) has had its traps [145]. In summary, already a number of promising nucleic acid strategies exist, and these certainly present less hurdles for delivery than their protein counterpart, as they are smaller, less antigenic, and can bypass certain resistance mechanisms. Nevertheless, further improvements in nonviral targeted delivery appear required to increase the efficacy of such therapies.